Skip to main content

Table 3 Comparison of primary debulking surgery and neoadjuvant chemotherapy

From: Therapeutic strategies in epithelial ovarian cancer

 

Primary debulking surgery

Neoadjuvant chemotherapy

Number of patients

336

334

Age: Median (range)

62 (25-86)

63 (33-81)

Stage

257 (76.5%)

253 (75.7%)

   IIIc

77 (22.9%)

81 (24.3%)

   IV

2 (0.6%)

0 (0%)

PFS

12 months

12 months

OS

29 months

30 months